Theseus Pharmaceuticals Inc (THRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Operating Expenses | 54,086 | 27,336 | 6,836 | 4,942 | 0 |
| Operating Income | -54,086 | -27,336 | -6,836 | -4,942 | N/A |
| Other Income | 3,478 | 28 | -5,161 | -2,241 | 0 |
| Pre-tax Income | -50,608 | -27,308 | -11,997 | -7,183 | 0 |
| Net Income Continuous | -50,608 | -27,308 | -11,997 | -7,183 | N/A |
| Net Income | $-50,608 | $-27,308 | $-11,997 | $-7,183 | $N/A |
| EPS Basic Total Ops | -1.31 | -2.84 | -21.10 | -59.77 | N/A |
| EPS Basic Continuous Ops | -1.31 | -2.84 | -21.08 | -59.86 | N/A |
| EPS Diluted Total Ops | -1.31 | -2.84 | -21.10 | -59.77 | N/A |
| EPS Diluted Continuous Ops | -1.31 | -2.84 | -21.08 | -59.86 | N/A |
| EPS Diluted Before Non-Recurring Items | -1.31 | -2.84 | N/A | N/A | N/A |
| EBITDA(a) | $-54,691 | $-27,334 | $-6,834 | $-4,940 | $N/A |